Robert Andrade - Jun 2, 2021 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role: Chief Financial Officer
Signature: /s/ Robert Andrade, Chief Financial Officer
Stock symbol: FENC
Transactions as of: Jun 2, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/3/2021, 11:58 AM
Next filing: Dec 20, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FENC	Stock Option (right to buy)	Award	$0	+100K		$0.00	100K	Jun 2, 2021	Common Shares	100K	$7.53	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 2, 2021, Robert Andrade was granted an incentive stock option to purchase 100,000 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
F2	1/3 of the shares subject to this option shall vest immediately and may be exercised as of June 2, 2022 (the "Vesting Commencement Date"). 1/24 of the shares subject to this option shall vest immediately and may be exercised as of the last day of each month following the Vesting Commencement Date. As of May 31, 2024 and thereafter, 100% of the total number of shares subject to this option shall be vested.

Content

On June 2, 2021, Robert Andrade was granted an incentive stock option to purchase 100,000 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan.

1/3 of the shares subject to this option shall vest immediately and may be exercised as of June 2, 2022 (the "Vesting Commencement Date"). 1/24 of the shares subject to this option shall vest immediately and may be exercised as of the last day of each month following the Vesting Commencement Date. As of May 31, 2024 and thereafter, 100% of the total number of shares subject to this option shall be vested.